153 related articles for article (PubMed ID: 29540343)
1. Genome-Wide DNA Methylation in Prediagnostic Blood and Bladder Cancer Risk in the Women's Health Initiative.
Jordahl KM; Randolph TW; Song X; Sather CL; Tinker LF; Phipps AI; Kelsey KT; White E; Bhatti P
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):689-695. PubMed ID: 29540343
[No Abstract] [Full Text] [Related]
2. Mediation by differential DNA methylation of known associations between single nucleotide polymorphisms and bladder cancer risk.
Jordahl KM; Phipps AI; Randolph TW; Tinker LF; Nassir R; Hou L; Anderson GL; Kelsey KT; White E; Bhatti P
BMC Med Genet; 2020 Nov; 21(1):228. PubMed ID: 33213418
[TBL] [Abstract][Full Text] [Related]
3. Differential DNA methylation in blood as a mediator of the association between cigarette smoking and bladder cancer risk among postmenopausal women.
Jordahl KM; Phipps AI; Randolph TW; Tindle HA; Liu S; Tinker LF; Kelsey KT; White E; Bhatti P
Epigenetics; 2019 Nov; 14(11):1065-1073. PubMed ID: 31232174
[TBL] [Abstract][Full Text] [Related]
4. Epigenome-wide association study of diet quality in the Women's Health Initiative and TwinsUK cohort.
Do WL; Whitsel EA; Costeira R; Masachs OM; Le Roy CI; Bell JT; Staimez LR; Stein AD; Smith AK; Horvath S; Assimes TL; Liu S; Manson JE; Shadyab AH; Li Y; Hou L; Bhatti P; Jordahl K; Narayan KMV; Conneely KN
Int J Epidemiol; 2021 May; 50(2):675-684. PubMed ID: 33354722
[TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case-Control Study.
FitzGerald LM; Naeem H; Makalic E; Schmidt DF; Dowty JG; Joo JE; Jung CH; Bassett JK; Dugue PA; Chung J; Lonie A; Milne RL; Wong EM; Hopper JL; English DR; Severi G; Baglietto L; Pedersen J; Giles GG; Southey MC
Prostate; 2017 Apr; 77(5):471-478. PubMed ID: 28116812
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation of DNA damage repair (DDR) genes in human tumor entities:
Mijnes J; Veeck J; Gaisa NT; Burghardt E; de Ruijter TC; Gostek S; Dahl E; Pfister D; Schmid SC; Knüchel R; Rose M
Clin Epigenetics; 2018; 10():15. PubMed ID: 29445424
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer.
Marsit CJ; Koestler DC; Christensen BC; Karagas MR; Houseman EA; Kelsey KT
J Clin Oncol; 2011 Mar; 29(9):1133-9. PubMed ID: 21343564
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer.
Ilijazi D; Pulverer W; Ertl IE; Lemberger U; Kimura S; Abufaraj M; D'Andrea D; Pradere B; Bruchbacher A; Graf A; Soria F; Susani M; Haitel A; Molinaro L; Pycha A; Comploj E; Pabinger S; Weinhäusel A; Egger G; Shariat SF; Hassler MR
Cells; 2020 Aug; 9(8):. PubMed ID: 32764425
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
[TBL] [Abstract][Full Text] [Related]
10. Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer.
Kitchen MO; Bryan RT; Emes RD; Glossop JR; Luscombe C; Cheng KK; Zeegers MP; James ND; Devall AJ; Mein CA; Gommersall L; Fryer AA; Farrell WE
Epigenetics; 2016 Mar; 11(3):237-46. PubMed ID: 26929985
[TBL] [Abstract][Full Text] [Related]
11. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study.
Moore LE; Pfeiffer RM; Poscablo C; Real FX; Kogevinas M; Silverman D; García-Closas R; Chanock S; Tardón A; Serra C; Carrato A; Dosemeci M; García-Closas M; Esteller M; Fraga M; Rothman N; Malats N
Lancet Oncol; 2008 Apr; 9(4):359-66. PubMed ID: 18339581
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of smoking-related white blood cell DNA methylation markers and risk of bladder cancer.
Vermeulen R; Bodinier B; Dagnino S; Wada R; Wang X; Silverman D; Albanes D; Freedman N; Rahman M; Bell D; Chadeau-Hyam M; Rothman N
Eur J Epidemiol; 2024 Apr; 39(4):393-407. PubMed ID: 38554236
[TBL] [Abstract][Full Text] [Related]
13. A three-gene methylation marker panel for the nodal metastatic risk assessment of muscle-invasive bladder cancer.
Stubendorff B; Wilhelm K; Posselt K; Catto J; Hartmann A; Bertz S; Füssel S; Novotny V; Toma M; Gajda M; Lehmann J; Wunderlich H; Grimm MO; Stöckle M; Junker K
J Cancer Res Clin Oncol; 2019 Apr; 145(4):811-820. PubMed ID: 30603903
[TBL] [Abstract][Full Text] [Related]
14. Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine.
Chen PC; Tsai MH; Yip SK; Jou YC; Ng CF; Chen Y; Wang X; Huang W; Tung CL; Chen GC; Huang MM; Tong JH; Song EJ; Chang DC; Hsu CD; To KF; Shen CH; Chan MW
BMC Med Genomics; 2011 May; 4():45. PubMed ID: 21599969
[TBL] [Abstract][Full Text] [Related]
15. Association of internal smoking dose with blood DNA methylation in three racial/ethnic populations.
Park SL; Patel YM; Loo LWM; Mullen DJ; Offringa IA; Maunakea A; Stram DO; Siegmund K; Murphy SE; Tiirikainen M; Le Marchand L
Clin Epigenetics; 2018 Aug; 10(1):110. PubMed ID: 30139389
[TBL] [Abstract][Full Text] [Related]
16. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.
Malekzadeh K; Sobti RC; Nikbakht M; Shekari M; Hosseini SA; Tamandani DK; Singh SK
Cancer Invest; 2009 Jan; 27(1):70-80. PubMed ID: 19160091
[TBL] [Abstract][Full Text] [Related]
17. Establishment of diagnostic criteria for upper urinary tract urothelial carcinoma based on genome-wide DNA methylation analysis.
Fujimoto M; Arai E; Tsumura K; Yotani T; Yamada Y; Takahashi Y; Maeshima AM; Fujimoto H; Yoshida T; Kanai Y
Epigenetics; 2020 Dec; 15(12):1289-1301. PubMed ID: 32498593
[TBL] [Abstract][Full Text] [Related]
18. Association of secondhand smoke exposures with DNA methylation in bladder carcinomas.
Wilhelm-Benartzi CS; Christensen BC; Koestler DC; Houseman EA; Schned AR; Karagas MR; Kelsey KT; Marsit CJ
Cancer Causes Control; 2011 Aug; 22(8):1205-13. PubMed ID: 21660454
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte-adjusted epigenome-wide association studies of blood from solid tumor patients.
Langevin SM; Houseman EA; Accomando WP; Koestler DC; Christensen BC; Nelson HH; Karagas MR; Marsit CJ; Wiencke JK; Kelsey KT
Epigenetics; 2014 Jun; 9(6):884-95. PubMed ID: 24671036
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case-control study.
Dugué PA; Brinkman MT; Milne RL; Wong EM; FitzGerald LM; Bassett JK; Joo JE; Jung CH; Makalic E; Schmidt DF; Park DJ; Chung J; Ta AD; Bolton DM; Lonie A; Longano A; Hopper JL; Severi G; Saffery R; English DR; Southey MC; Giles GG
Br J Cancer; 2016 Sep; 115(6):664-73. PubMed ID: 27490804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
